Literature DB >> 27283533

Heme Oxygenase-1 and Carbon Monoxide in the Heart: The Balancing Act Between Danger Signaling and Pro-Survival.

Leo E Otterbein1, Roberta Foresti2,3, Roberto Motterlini2,3.   

Abstract

Understanding the processes governing the ability of the heart to repair and regenerate after injury is crucial for developing translational medical solutions. New avenues of exploration include cardiac cell therapy and cellular reprogramming targeting cell death and regeneration. An attractive possibility is the exploitation of cytoprotective genes that exist solely for self-preservation processes and serve to promote and support cell survival. Although the antioxidant and heat-shock proteins are included in this category, one enzyme that has received a great deal of attention as a master protective sentinel is heme oxygenase-1 (HO-1), the rate-limiting step in the catabolism of heme into the bioactive signaling molecules carbon monoxide, biliverdin, and iron. The remarkable cardioprotective effects ascribed to heme oxygenase-1 are best evidenced by its ability to regulate inflammatory processes, cellular signaling, and mitochondrial function ultimately mitigating myocardial tissue injury and the progression of vascular-proliferative disease. We discuss here new insights into the role of heme oxygenase-1 and heme on cardiovascular health, and importantly, how they might be leveraged to promote heart repair after injury.
© 2016 American Heart Association, Inc.

Entities:  

Keywords:  carbon monoxide; heme oxygenase-1; inflammation; mitochondria; myocardial ischemia

Mesh:

Substances:

Year:  2016        PMID: 27283533      PMCID: PMC4905590          DOI: 10.1161/CIRCRESAHA.116.306588

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  221 in total

1.  Evidence suggesting that the two forms of heme oxygenase are products of different genes.

Authors:  I Cruse; M D Maines
Journal:  J Biol Chem       Date:  1988-03-05       Impact factor: 5.157

2.  Cardiac-specific expression of heme oxygenase-1 protects against ischemia and reperfusion injury in transgenic mice.

Authors:  S F Yet; R Tian; M D Layne; Z Y Wang; K Maemura; M Solovyeva; B Ith; L G Melo; L Zhang; J S Ingwall; V J Dzau; M E Lee; M A Perrella
Journal:  Circ Res       Date:  2001-07-20       Impact factor: 17.367

3.  Gene transfer as a strategy to achieve permanent cardioprotection II: rAAV-mediated gene therapy with heme oxygenase-1 limits infarct size 1 year later without adverse functional consequences.

Authors:  Qianhong Li; Yiru Guo; Qinghui Ou; Wen-Jian Wu; Ning Chen; Xiaoping Zhu; Wei Tan; Fangping Yuan; Buddhadeb Dawn; Li Luo; Gregory N Hunt; Roberto Bolli
Journal:  Basic Res Cardiol       Date:  2011-07-22       Impact factor: 17.165

4.  Induction of HSP 32 gene in hypoxic cardiomyocytes is attenuated by treatment with N-acetyl-L-cysteine.

Authors:  D R Borger; D A Essig
Journal:  Am J Physiol       Date:  1998-03

5.  Protection against ischemia/reperfusion injury in cardiac and renal transplantation with carbon monoxide, biliverdin and both.

Authors:  Atsunori Nakao; Joao Seda Neto; Shinichi Kanno; Donna B Stolz; Kei Kimizuka; Fang Liu; Fritz H Bach; Timothy R Billiar; Augustine Mk Choi; Leo E Otterbein; Noriko Murase
Journal:  Am J Transplant       Date:  2005-02       Impact factor: 8.086

6.  Carbon monoxide suppresses arteriosclerotic lesions associated with chronic graft rejection and with balloon injury.

Authors:  Leo E Otterbein; Brian S Zuckerbraun; Manabu Haga; Fang Liu; Ruiping Song; Anny Usheva; Christina Stachulak; Natalya Bodyak; R Neal Smith; Eva Csizmadia; Shivraj Tyagi; Yorihiro Akamatsu; Richard J Flavell; Timothy R Billiar; Edith Tzeng; Fritz H Bach; Augustine M K Choi; Miguel P Soares
Journal:  Nat Med       Date:  2003-01-21       Impact factor: 53.440

7.  HO-1 activation can attenuate cardiomyocytic apoptosis via inhibition of NF-kappaB and AP-1 translocation following cardiac global ischemia and reperfusion.

Authors:  Chi-Hsiao Yeh; Tzu-Ping Chen; Yao-Chang Wang; Yu-Min Lin; Pyng Jing Lin
Journal:  J Surg Res       Date:  2008-09-04       Impact factor: 2.192

Review 8.  Oxidative effects of heme and porphyrins on proteins and lipids.

Authors:  S H Vincent
Journal:  Semin Hematol       Date:  1989-04       Impact factor: 3.851

9.  Carbon monoxide protects against liver failure through nitric oxide-induced heme oxygenase 1.

Authors:  Brian S Zuckerbraun; Timothy R Billiar; Sherrie L Otterbein; Peter K M Kim; Fang Liu; Augustine M K Choi; Fritz H Bach; Leo E Otterbein
Journal:  J Exp Med       Date:  2003-12-01       Impact factor: 14.307

10.  Cardioprotection by S-nitrosation of a cysteine switch on mitochondrial complex I.

Authors:  Edward T Chouchani; Carmen Methner; Sergiy M Nadtochiy; Angela Logan; Victoria R Pell; Shujing Ding; Andrew M James; Helena M Cochemé; Johannes Reinhold; Kathryn S Lilley; Linda Partridge; Ian M Fearnley; Alan J Robinson; Richard C Hartley; Robin A J Smith; Thomas Krieg; Paul S Brookes; Michael P Murphy
Journal:  Nat Med       Date:  2013-05-26       Impact factor: 53.440

View more
  58 in total

1.  Macrophage metabolic adaptation to heme detoxification involves CO-dependent activation of the pentose phosphate pathway.

Authors:  Gael F P Bories; Scott Yeudall; Vlad Serbulea; Todd E Fox; Brant E Isakson; Norbert Leitinger
Journal:  Blood       Date:  2020-09-24       Impact factor: 22.113

Review 2.  Nrf2 at the heart of oxidative stress and cardiac protection.

Authors:  Qin M Chen; Anthony J Maltagliati
Journal:  Physiol Genomics       Date:  2017-11-29       Impact factor: 3.107

Review 3.  Danger signals from mitochondrial DAMPS in trauma and post-injury sepsis.

Authors:  C J Hauser; L E Otterbein
Journal:  Eur J Trauma Emerg Surg       Date:  2018-05-24       Impact factor: 3.693

4.  Pinocembrin Attenuates Mitochondrial Dysfunction in Human Neuroblastoma SH-SY5Y Cells Exposed to Methylglyoxal: Role for the Erk1/2-Nrf2 Signaling Pathway.

Authors:  Marcos Roberto de Oliveira; Alessandra Peres; Gustavo Costa Ferreira
Journal:  Neurochem Res       Date:  2016-12-21       Impact factor: 3.996

5.  Astrocyte heme oxygenase-1 reduces mortality and improves outcome after collagenase-induced intracerebral hemorrhage.

Authors:  Jing Chen-Roetling; Pramod Kamalapathy; Yang Cao; Wei Song; Hyman M Schipper; Raymond F Regan
Journal:  Neurobiol Dis       Date:  2017-03-18       Impact factor: 5.996

Review 6.  The role of carbon monoxide and heme oxygenase in the prevention of sickle cell disease vaso-occlusive crises.

Authors:  Edward Gomperts; John D Belcher; Leo E Otterbein; Thomas D Coates; John Wood; Brett E Skolnick; Howard Levy; Gregory M Vercellotti
Journal:  Am J Hematol       Date:  2017-04-29       Impact factor: 10.047

7.  EET intervention on Wnt1, NOV, and HO-1 signaling prevents obesity-induced cardiomyopathy in obese mice.

Authors:  Jian Cao; Shailendra P Singh; John A McClung; Gregory Joseph; Luca Vanella; Ignazio Barbagallo; Houli Jiang; John R Falck; Michael Arad; Joseph I Shapiro; Nader G Abraham
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-06-02       Impact factor: 4.733

8.  Development of Triggerable, Trackable, and Targetable Carbon Monoxide Releasing Molecules.

Authors:  Livia S Lazarus; Abby D Benninghoff; Lisa M Berreau
Journal:  Acc Chem Res       Date:  2020-09-15       Impact factor: 22.384

9.  Differential gene responses 3 days following infarction in the fetal and adolescent sheep heart.

Authors:  Mitchell C Lock; Ross L Tellam; Jack R T Darby; Jia Yin Soo; Doug A Brooks; Christopher K Macgowan; Joseph B Selvanayagam; Enzo R Porrello; Mike Seed; Maureen Keller-Wood; Janna L Morrison
Journal:  Physiol Genomics       Date:  2020-01-21       Impact factor: 3.107

Review 10.  Heat shock protein 90 inhibition and multi-target approach to maximize cardioprotection in ischaemic injury.

Authors:  Shant Der Sarkissian; Henry Aceros; Pierre-Marc Williams; Catherine Scalabrini; Mélanie Borie; Nicolas Noiseux
Journal:  Br J Pharmacol       Date:  2020-05-23       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.